Titre:
  • European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2024
Auteur:Garbe, Claus; Amaral, Teresa; Peris, Ketty; Hauschild, Axel; Arenberger, Petr; Basset-seguin, Nicole; Bastholt, Lars; Bataille, Véronique; Brochez, Lieve; Del Marmol, Véronique; Dreno, Brigitte; Eggermont, Alexander A.M.M.; Fargnoli, Maria Maria Concetta M.C.; Forsea, Ana-Maria; Hoeller, Christoph; Kaufmann, Roland; Kelleners-Smeets, Nicole WJ; Lallas, Aimilios; Lebbe, Céleste; Leiter, Ulrike; Longo, Caterina; Malvehy, Josep; Moreno-Ramirez, David; Nathan, Paul; Pellacani, Giovanni; Saiag, Philippe; Stockfleth, Eggert; Stratigos, Alexander; van Akkooi, Alexander A.C.J.; Vieira, Ricardo; Zalaudek, Iris; Lorigan, Paul; Mandala, Mario
Informations sur la publication:European journal of cancer, 215, 115153
Statut de publication:Publié, 2025-01
Sujet CREF:Cancérologie
Mots-clés:Adjuvant therapy
BRAF and MEK inhibitors
Brain metastases
Cutaneous melanoma
Immune checkpoint inhibitors
Neoadjuvant therapy
Targeted therapy
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2024.115153
info:pii/S095980492401760X
info:scp/85212612826
info:pmid/39709737